Parent-Augmented Cognitive Behavioral Therapy to Treat Children With Specific Phobias

NCT00509951 | Completed

• 2 other identifiers: R01MH074777DSIR 84-CTS
• Study Type: interventional
• Target: 154
• Locations: 1 country
• Sites: 1

Brief Summary

This study will compare the effectiveness of two types of cognitive behavioral therapy, one-session exposure treatment and family-enhanced one-session exposure treatment, in treating children with specific phobias.

Conditions

Anxiety Disorders; Specific Phobia

Keywords

Neuroses; Evidence-Based Treatment; Clinical Investigation; Young Patients; Phobic Disorders; Fear; Phobias

Outcome Measures

Primary Outcomes (2)

• Anxiety Disorders Interview Schedule for DSM-IV: Presence of Specific Phobia

  Measured at Year 1

• Clinical Global Impression: Severity of Specific Phobia

  Measured at Year 1

Study Arms (2)

1

ACTIVE COMPARATOR

One-session exposure treatment (OST)

Behavioral: One-session exposure treatment

2

EXPERIMENTAL

Family-enhanced (augmented) OST

Behavioral: Augmented one-session exposure treatment

Interventions

One-session exposure treatment BEHAVIORAL

Participants receiving OST will attend one extended treatment session, lasting up to 3 hours in duration. During this session, the child will be taught a number of cognitive and behavioral skills to deal effectively with the feared situation or object. The child will also be exposed to the feared situation or object in a highly structured, safe, and controlled manner.

1

Augmented one-session exposure treatment BEHAVIORAL

Family-enhanced OST (augmented OST) involves the parents of affected children and provides the parents with strategies to assist their children in overcoming phobias. Participants receiving augmented OST will attend the same type of extended treatment session, but, in addition, their parent or guardian will attend a 3-hour session.

Also known as: Family-enhanced OST

2

Eligibility Criteria

• Age: 7 Years - 14 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17)

You may qualify if:

• Enrolled in a regular classroom setting
• Possess at least an average intellectual ability as documented by school ability records
• Meets DSM-IV criteria for specific phobia and scores 4 or above on the clinician severity rating scale of the ADIS-C/P
• A parent or caregiver agrees to participate in the treatment
• Parent or guardian willing to provide informed consent

You may not qualify if:

• Significant medical disorder (e.g., cerebral palsy, deafness) that would interfere with study participation
• Already receiving psychological treatment (with the exception of minimal intervention in the school setting)
• Currently receiving psychotropic medication for a psychological disorder, with the exception of attention deficit hyperactivity disorder (ADHD). If the child is receiving stimulant or other medication for management of ADHD symptoms, it must be documented that pharmacological treatment has been stabilized.
• Blood-injection-injury type of specific phobia

Sponsors & Collaborators

• Virginia Polytechnic Institute and State University: lead
• National Institute of Mental Health (NIMH): collaborator

Study Sites (1)

Child Study Center

Blacksburg, Virginia, 24060, United States

Location

MeSH Terms

Conditions

Anxiety Disorders; Phobia, Specific; Neurotic Disorders; Phobic Disorders

Condition Hierarchy (Ancestors)

Mental Disorders

Study Officials

• Thomas H. Ollendick, PhD

  Department of Psychology, Virginia Tech

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: University Distinguished Professor

Study Record Dates

• First Submitted: July 30, 2007
• First Posted: August 1, 2007
• Study Start: July 1, 2007
• Primary Completion: May 1, 2012
• Study Completion: May 1, 2012
• Last Updated: June 7, 2013

Record last verified: 2013-06

Locations

US (1)